Straight Talk: Do Orthopedic Companies Really Value Clinical Data?

I recently shared a blunt thought on LinkedIn:
"I’ve come to the conclusion that everyone in orthopedics ‘says’ they want clinical data, but their ‘behavior’ says they don’t value it.
Tell me I’m wrong.”

The conversation that followed was insightful, with industry leaders weighing in on the disconnect between rhetoric and reality.
Here’s what stood out.
The Talk vs. The Walk
Sean Finnerty, a sales executive in biotech, agreed, pointing to Kuros Biosciences as a rare example of a company backing its claims with Level 1 clinical data. But many others echoed my sentiment. Scott Day from Nova...


Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.